Showing results (1261-1270 of 2,609) with videos related to
Sort By:
Pageof 261
Oncology Research|June 26, 2026
Dual Immune Checkpoint Blockade in Synchronous Hepatocellular and Renal Cell Carcinoma: A Real-World Case Report of Durable Dual ResponsePiera Federico, Maria Anna Canciello, Barbara Granata, et al.Oncology Research|June 26, 2026
Monoclonal Antibodies and Derivatives: Therapeutic Tools for CancerAlessandro PoggiOncology Research|June 26, 2026
Engineering the Future of ADCs in Non-Small Cell Lung CancerMi Rim Kim, Jason Lau, Michele Maffezzoli, et al.Oncology Research|June 26, 2026
Emerging Nanocarrier Strategies for Optimized Drug Delivery in the Treatment of Primary Bone CancerLindokuhle M Ngema, Samson A Adeyemi, Yahya E ChoonaraOncology Research|June 26, 2026
Autocrine Motility Factor-Derived Tetradecapeptides as Dual-Action Chemosensitizers: Bridging Cell Competition Mechanisms with Clinical MDR Reversal in Hematological MalignanciesChangyul Kim, Yu Ju Jung, Da Hee Son, et al.Oncology Research|June 26, 2026
Immunometabolic Reprogramming in Hepatocellular Carcinoma Mechanisms, Biomarkers, and Therapeutic ImplicationsGuodong Yu, Weiying Ge, Hongliang Yao, et al.Oncology Research|June 26, 2026
Single-Cell Sequencing Reveals the Heterogeneity of Glioma and Identifies IGFBP2 as A Potential Therapeutic TargetJian-Lei Kang, Yu-Jie Xu, Qi-Tai Zhao, et al.Oncology Research|June 26, 2026
PRDM1 Drives a TIM3+ Macrophage Immunosuppressive Niche via LGALS9 Signaling in Prostate Cancer ProgressionYangyang Zhang, Ilyar Mamtili, Yonghao Chen, et al.Oncology Research|February 6, 2009
Neutral pH hydrogen-enriched electrolyzed water achieves tumor-preferential clonal growth inhibition over normal cells and tumor invasion inhibition concurrently with intracellular oxidant repressionYasukazu Saitoh, Hajime Okayasu, Li Xiao, et al.Pageof 261